Skip to main content

Encompass Health Corp

EHC
Exchange
NYSE
Industry
Services-Hospitals
SEC CIK
0000785161

In the last 90 days, Encompass Health Corp insiders filed 0 open-market purchases and 2 sales; 602 institutions reported holding it in 13F filings for Q2 2026, worth $9.63B in total; no superinvestor holds it.

Key figures

Market capClose on Nov 11, 2026
$14.0B
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $1.22M in total
2
13F holdersQ2 2026, +23 vs. previous quarter
602
13F valueReported value at the end of Q2 2026
$9.63B
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$5.94B
+10.5% year over year
Net income, FY2025
$566.2M
+24.2% year over year
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q3 FY2026
$1.61B
+8.9% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
3.61M
Shares sold short
Change
+301.4K
+9.1% vs. previous
Days to cover
2.69
At average daily volume

Superinvestors holding EHC, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding EHC at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Encompass Health Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 1, 2026 (view filing)12:21 PM ETAug 311 dayPrice Andrew LChief Accounting OfficerSSaleEncompass Health Common Stock−5.21K$120.93−$630.2K−7.0%69.5K after
Sep 1, 2026 (view filing)12:21 PM ETAug 311 dayDarby John PatrickEVP, Gen Counsel & SecretarySSaleEncompass Health Common Stock−4.86K$121.09−$588.3K−6.1%75.0K after
Aug 11, 2026 (view filing)2:47 PM ETAug 101 dayColtharp Douglas EEVP & Chief Financial OfficerSSaleEncompass Health Common Stock−18.9K$125.38−$2.37M−27.2%50.5K after
Aug 11, 2026 (view filing)2:47 PM ETAug 101 dayTarr Mark JPresident & CEOSSaleEncompass Health Common Stock−173.1K$125.47−$21.7M−39.3%267.8K after2 lots
Aug 11, 2026 (view filing)2:47 PM ETAug 101 dayDarby John PatrickEVP, Gen Counsel & SecretarySSaleEncompass Health Common Stock−8.91K$125.95−$1.12M−10.6%75.0K after
May 18, 2026 (view filing)May 153 daysColtharp Douglas EEVP & Chief Financial OfficerSSaleEncompass Health Common Stock−27.7K$106.83−$2.96M−28.5%69.4K after2 lots
May 12, 2026 (view filing)May 111 dayTuer Patrick WilliamEVP, Chief Operating OfficerSSaleEncompass Health Common Stock−682$104.56−$71.3K−2.7%24.8K after
Mar 10, 2026 (view filing)Mar 91 dayFay EdmundSr. Vice Pres. and TreasurerSSaleEncompass Health Common Stock−11.9K$107.00−$1.28M−11.8%89.3K after
Feb 12, 2026 (view filing)Feb 111 dayTarr Mark JPresident & CEOSSaleEncompass Health Common Stock−150.0K$111.64−$16.7M−28.5%377.1K after7 lots
Feb 10, 2026 (view filing)Feb 10Same dayTuer Patrick WilliamEVP, Chief Operating OfficerSSaleEncompass Health Common Stock−2.80K$107.62−$301.8K−14.9%16.0K after

Top 10 13F holders, Q2 2026

See all 602 holders

The largest institutional positions in Encompass Health Corp at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding EHC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.10,484,385$1.06B0.02%−284,328−2.6%Reduced
Price T Rowe Associates Inc5,055,801$511.0M0.05%+455,252+9.9%Added
Vanguard Portfolio Management LLC4,924,664$497.8M0.02%−34,881−0.7%Reduced
Vanguard Capital Management LLC4,475,896$452.4M0.01%+9,659+0.2%Added
Wellington Management Group LLP3,278,739$331.4M0.06%−570,116−14.8%Reduced
State Street Corp3,185,798$322.0M0.01%+40,824+1.3%Added
Citadel Advisors LLC2,563,104$259.1M0.15%+2,051,217+400.7%Added
Fuller & Thaler Asset Management, Inc.2,460,657$248.7M0.68%+230,678+10.3%Added
Alliancebernstein L.P.2,471,751$239.1M0.08%−149,494−5.7%Reduced
Two Sigma Investments, LP2,267,668$229.2M0.17%+45,567+2.1%Added

Holders of 5% or more of EHC

See all 2 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Encompass Health Corp.

Largest holders of EHC from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Vanguard Capital Management LLC13G5.26%5.23M sharesNewApr 29, 20261 filingApr 29, 2026SEC
Price T Rowe Associates Inc13G5.10%5.06M sharesNewAug 14, 20261 filingAug 14, 2026SEC

3 members of Congress reported 7 trades in Encompass Health Corp since 2020. Newest filings:

  1. Lisa C. McClain

    House · MI · Nov 21, 2025

    Buy$1K-$15K

  2. Lisa C. McClain

    House · MI · Nov 21, 2025

    Sell$1K-$15K

  3. Lisa C. McClain

    House · MI · Nov 21, 2025

    Sell$1K-$15K

  4. Lisa C. McClain

    House · MI · Aug 13, 2025

    Buy$1K-$15K

  5. Peter Meijer

    House · MI · Mar 16, 2021

    Sell$1K-$15K